• ScreenPro Security Inc. (SCRN) has filed its financial statements for the second quarter of 2021
  • As of June 30, 2021, the company reported revenue of nearly $5.5 million
  • ScreenPro remains focused on expanding its COVID-19 testing business
  • ScreenPro is a screening medical technology company
  • ScreenPro Security Inc. (SCRN) is up 16.67 per cent, trading at $0.035 per share

ScreenPro Security Inc. (SCRN) has filed its financial statements for the second quarter of 2021.

The company made strong progress throughout the second quarter by identifying revenue opportunities, rebalancing staff and payroll, opening a testing office in Toronto and Vancouver, and consolidating its supply chain pipelines.

As of June 30, 2021, the company reported revenue of nearly $5.5 million and net income of $140,485. The company also significantly improved its cash balance, ending the quarter with $963,124 compared to $32 in cash in Q2 2020.

Andrew Ryu, CEO of ScreenPro, commented on the quarterly results.

“We have built the base for an incredible life sciences and health care businesses, we are getting more stability in revenues, our product offerings are increasing, and the company had a profit after only two quarters.”

“As a company,” he added, “we share a fundamental commitment to all of our shareholders to deliver value to all of them, for the future success of ScreenPro shareholders, our employees and our customers.”

ScreenPro remains focused on expanding its COVID-19 testing business. The company expects to see growth in the second half of 2021 as different testing verticals and new concierge medical services are launched in the custom care management market.

Given the significant surge in the need for additional healthcare resources, establishing alternative healthcare options becomes critical. Testing, coupled with contact tracing, is a COVID-19 preventative action that will continue for years to come.

ScreenPro understands that non-acute healthcare can mitigate exposing patients and their families to COVID-19.

ScreenPro is a screening medical technology company, providing turnkey screening solutions with its alerting software, GoStop.

ScreenPro Security Inc. (SCRN) is up 16.67 per cent, trading at $0.035 per share as of 1:19 pm ET.

More From The Market Online

Independent tests of BlackBerry cyber defense scores solid results

A new study finds that BlackBerry’s (TSX:BB) endpoint protection platform blocked the most cyberattacks while using fewer system resources.
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.